Email : info@otcjournal.com
URL : http://www.otcjournal.com

To OTC Journal Subscribers:

Last Friday we sent you our newsletter which featured some information on an upcoming IPO, Qiao Xing Universal Telephone. We gave you the phone number of the underwriting brokerage firm, Barron Chase Securities, and gave you a contact at the firm to call for a preliminary prospectus. The phone number is 800-747-1202, and the contact is Marie Lima.

On Monday the switchboard at Barron Chase was so overwhelmed with calls that they could not handle the incoming phone traffic. Most callers received no answer or a busy signal.

If you wish to receive the preliminary prospectus on Qiao Xing, simply click on: OTCJournal E-Mail, and send us your name, phone number, and the best time to call. We will be sure to have a representative of Barron Chase contact you directly within the next several days.

If you missed the issue from last Friday, click on Issue 14 to read it.

To clarify one area that we had several questions on from subscribers: We have not been compensated by Qiao Xing Universal Telephone, Barron Chase Securities, or any other party in any way for providing our subscribers the information on this Company.

Disclaimer

The OTCJournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. All statements and expressions are the sole opinions of the editors and are subject to change without notice. This profile is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with which they are affiliated, may own stock in and have other financial dealings with the companies who appear in the publication. The affiliate Company may exercise the aforementioned options anytime at its sole discretion. The OTCJournal.com critiques may contain forward looking statements relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.